Public Profile

Zoetis

Zoetis Inc., headquartered in the United States, is a leading global animal health company dedicated to supporting the health and well-being of livestock and companion animals. Founded in 1952, Zoetis has established itself as a pioneer in the veterinary pharmaceutical industry, with a diverse portfolio that includes vaccines, diagnostics, and therapeutics. With a strong presence in North America, Europe, and Asia, Zoetis is renowned for its innovative products that enhance animal health and productivity. The company’s commitment to research and development has led to significant milestones, including the introduction of groundbreaking treatments that address various health challenges in animals. Recognised for its market leadership, Zoetis continues to set industry standards, making it a trusted partner for veterinarians and animal producers worldwide.

DitchCarbon Score

How does Zoetis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

49

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Zoetis's score of 49 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

82%

Let us know if this data was useful to you

Zoetis's reported carbon emissions

In 2023, Zoetis reported total carbon emissions of approximately 232,804,000 kg CO2e, comprising 111,637,000 kg CO2e from Scope 1 and 121,167,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data for this year. Over the years, Zoetis has made significant strides in reducing its carbon footprint. For instance, in 2021, the total emissions were about 288,208,000 kg CO2e, indicating a reduction in emissions by approximately 55,404,000 kg CO2e by 2023. The company aims to become carbon neutral in its operations by 2030, demonstrating a long-term commitment to sustainability across all scopes of emissions. Zoetis's emissions data reflects a consistent effort to manage and reduce its environmental impact, aligning with industry standards for climate action. The company continues to focus on improving its operational efficiency and reducing its carbon intensity, contributing to a more sustainable future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201820192020202120222023
Scope 1
73,391,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
Scope 2
193,434,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
00,000,000
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zoetis's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zoetis is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zoetis is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Idexx Laboratories

US
Research and development services (73)
Updated 1 day ago

Biogen

US
Research and development services (73)
Updated 1 day ago

Eli Lilly and Company

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Allergan

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Mallinckrodt plc

IE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Boehringer Ingelheim International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers